Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

About the Company

湖北共创医药有限公司是一家中日合资企业,成立于2010年5月,是九州通医药集团股份有限公司和日本东邦药品株式会社合资成立的医药商业公司。公司以进口的药品、器械、日化品为主要经营产品,以零售药店、母婴连锁、商超卖场、医疗机构为主要客户对象,并为客户提供信息、物流等各项增值服务。截止2024年1月1日,公司注册资金20000万元人民币,办公地址位于武汉市汉阳区龙阳大道九州通大厦B栋6楼。 公司在短暂的时间内快速发展,营销网络遍布了北京、上海、重庆、广州、新疆、西藏、江苏、黑龙江、吉林、辽宁、武汉等全中国三十多个省会和直辖市,产品配送到全中国地级、县级以及乡镇市场。湖北共创医药有限公司凭借九州通集团拥有了上游供货商9000余家,下游客户10,0000余家,已将单产品系做到年度2000万元的销售业绩。业务网络覆盖全国商业分销、OTC终端、医疗机构、大型商超、社区便利店等。 在九州通医药集团的鼎力支持下,未来2-3年,湖北共创医药有限公司将建成超过20家的省级办事处、50家地级办事处、300个县级、乡镇配送点,业务覆盖率达到全国95%以上的行政区域,使湖北共创成为以经营广泛、管理严格、服务真诚、为客户创造价值而著称的国际大型现代医药商业企业,为中国医药商业及人类的健康事业做出更大贡献。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (14 open positions)

Manage
Note: How fast is hiring at 湖北共创医药有限公司 growing? 2025: 50 openings (up 456%), 2024: 9 openings (up 200%), 2023: 3 openings, 2021: 18 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

— What Are the Salaries Like? (28 records)

Manage
salary range: 3K - 15K, 96.4% of roles pay ¥6-15K
Note: salary statistics are based on 28 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 湖北共创医药有限公司?96.4% of positions earn 6-15K, Undergraduate salary: ¥。客户服务类 average salary ¥10.6K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at 湖北共创医药有限公司? We provide: 运营,跨境电商,地推,采购,内勤,城市经理,bd,业务发展,产品经理,发展经理,地区经理,大区经理,省区经理,销售. Click to view detailed salary analysis by job.

Related Industry Tags

Job Category

  • 客户服务类
    50% of total 50%
  • 贸易/物流/采购/运输类
    35.7% of total 35.7%
  • 销售类
    32.1% of total 32.1%
  • 市场/公关/媒介类
    17.9% of total 17.9%

Education

  • 大专
    92.9% of total 92.9%
  • 本科
    3.6% of total 3.6%
  • 不限
    3.6% of total 3.6%

Experience

  • 不限
    53.6% of total 53.6%
  • 3-5年
    32.1% of total 32.1%
  • 1-3年
    10.7% of total 10.7%
  • 5-10年
    3.6% of total 3.6%
View Detailed Analysis

What does 湖北共创医药有限公司 require? Who is 湖北共创医药有限公司 hiring? recruitment: 客户服务类占比最多占50%,其次是贸易/物流/采购/运输类占35.7%. What education can get in at ? 大专占比最多占92.9%,其次是本科占3.6%. Work experience required at ? 不限占比最多占53.6%,其次是3-5年占32.1%. Where are the job locations at ? 武汉占比最多占39.3%,其次是杭州占32.1%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 20,000万(元)
Legal Representative: 朴将虎
Date Established:
Credit Code: 914200006983402418
Registered Address: 武汉市汉阳区龙兴西街5号九州通总部大厦(1号楼)14楼1401-1407室

People who follow this company also follow

Competitors (Similar Companies)

彩超 医疗服务 骨科 医疗科研
“Large-scale pharmaceutical distribution enterprise”
“Wuhan Hengtaitong Technology Co., Ltd. is a high-tech enterprise integ”
“Although the processing is complicated, we dare not save labor; althou”
“Leading enterprise in Hubei pharmaceutical industry, one of China's to”
临床试验 诊所/门诊部 眼科 健康体检
医药 医药工业 中成药 制药/药业
生活服务 养老服务 办公空间 社区管理
“A technology-driven international pharmaceutical enterprise”
医用耗材 急救包 一次性医用耗材 伤口护理
医药 药物研发 研发 医药经济
“Technology Safeguards Health”
“Healthy world, people foremost”
心电诊断 心理咨询 医疗服务 生殖健康
诊所/门诊部 医疗科研 康复医学 脑卒中

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates